HELEN KWAK: Open Payments
NPI 1235767112 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,565 in 125 payments from 15 companies in 2025. Trend: 2023 $1,853 · 2024 $1,796 · 2025 $2,565
Food & beverage: $2,565
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $892 |
| Amgen Inc. | 33 | $552 |
| GlaxoSmithKline, LLC. | 9 | $277 |
| UCB, Inc. | 7 | $142 |
| Novartis Pharmaceuticals Corporation | 6 | $132 |
| Janssen Biotech, Inc. | 5 | $109 |
| GENZYME CORPORATION | 2 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Radius Health, Inc. | 2 | $59 |
| SHIELD THERAPEUTICS INC | 2 | $51 |
Products named: RINVOQ, SKYRIZI, BENLYSTA, EVENITY, Bimzelx, COSENTYX, UPLIZNA, ENBREL.
Industry payments across CA — which companies pay providers there.
